Oneok is growing aggressively through back-to-back multibillion-dollar acquisitions. These acquisitions, however, have come at a cost, and that has driven the stock lower.

LOUISVILLE, Ky., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today new development details related to its charitable gaming facility in Salem, New Hampshire.

The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models

VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that George Ng, Chief Executive Officer, and Patrick Lin, Chief Business & Strategy Officer and Founder, will attend the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California.

Incomplete Application Prevents Those Impacted from Assessing Competition Harms Incomplete Application Prevents Those Impacted from Assessing Competition Harms

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC, a leading provider of daily data and insights about change on Earth, today announced a multi-year low 9-figure agreement with the Swedish Armed Forces to rapidly deliver a suite of satellites, space-based data and awareness solutions to support the country's peace and security operations. This agreement marks Planet's third Satellite Services contract in twelve months, signaling robust demand for Planet's innovative, rapidly deployed space-based.

A Citi analyst upgraded Palantir stock to buy on views that 2026 estimates for the data analytics software maker will be revised upward.

Citi upgraded Palantir (NASDAQ: PLTR) stock to ‘Buy' on January 12, raising its 2026 price target from $210 to $235, a 31.26% upside.

Recent announcements from midstream names have reinforced the segment's commitment to shareholder returns. Distribution growth serves as an indicator of sector health, highlighting the midstream segment's ability to provide stable income despite broader market volatility.

For much of 2025, advisors, experts, and investors spent months speculating about when the Federal Reserve would begin trimming interest rates in earnest. Now that rate cuts are back on the table, 2026 is shaping up to be a different picture entirely.

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Alexandria Real Estate, Inc. (“Alexandria” or the “Company”) (NYSE: ARE) between January 27 , 202 5 through Octo ber 27 , 2025, inclusive (collectively, the “Class Period”). Should You Join This Class Action Lawsuit?

Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc.

Its $4.5 trillion market cap makes Nvidia Corp. (NASDAQ: NVDA) the most valuable company in the world.

Kelowna, British Columbia – TheNewswire - January 12, 2026 – Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to provide this Annual Letter from its Chief Executive Officer (“CEO”) Richard Christopher as a strategic update to all stakeholders. CEO Letter to Stakeholders

KELOWNA, BC / ACCESS Newswire / January 12, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide this Annual Letter from its Chief Executive Officer ("CEO") Richard Christopher as a strategic update to all stakeholders. CEO Letter to Stakeholders Dear Fellow Stakeholders, I'm truly honored to deliver Lexaria's Annual Letter from the CEO following my first full year in the position.

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to power precision oncology 10x also plans to establish a CLIA-certified laboratory to enable development of future innovative diagnostic tests PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc.

NOIDA, India, Jan. 12, 2026 /PRNewswire/ -- HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, has entered into a multi-year partnership to design, build and manage a future-ready IT infrastructure for The Magnum Ice Cream Company (TMICC), the world's largest ice cream company. In the coming years, HCLTech will deploy its AI Force platform to embed AI across TMICC's digital infrastructure.

Intends to nominate directors for election at the WBD 2026 Annual Meeting and solicit against the approval of the Netflix transaction Files suit seeking disclosure of basic information to enable WBD shareholders to make informed decision LOS ANGELES and NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ: PSKY) ("Paramount") today sent a letter to shareholders of Warner Bros. Discovery, Inc. (NASDAQ: WBD) ("WBD") outlining Paramount's next steps for delivering its superior, fully financed, all-cash offer of $30 per share to WBD shareholders.

SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.